There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .
Arriba: effects of an educational intervention on prescribing behaviour in prevention of CVD in general practice
Background : Evidence on the effectiveness of educational interventions on prescribing behaviour modification in prevention of cardiovascular disease is still insufficient . We evaluated the effects of a brief educational intervention on prescription of hydroxymethylglutaryl-CoA reductase inhibitors ( statins ) , inhibitors of platelet aggregation ( IPA ) , and antihypertensive agents ( AH ) . Design : Cluster r and omised controlled trial with continuous medical education ( CME ) groups of general practitioners ( GPs ) . Methods : Prescription of statins , IPA , and AH were verified prior to study start ( BL ) , immediately after index consultation ( IC ) , and at follow-up after 6 months ( FU ) . Prescription in patients at high risk ( > 15 % risk of a cardiovascular event in 10 years , based on the Framingham equation ) and no prescription in low-risk patients ( ≤ 15 % ) were considered appropriate . Results : An intervention effect on prescribing could only be found for IPA . Generally , changes in prescription over time were all directed towards higher prescription rates and persisted to FU , independent of risk status and group allocation . Conclusions : The active implementation of a brief evidence -based educational intervention on global risk in CVD did not lead directly to risk-adjusted changes in prescription . Investigations on an extended time scale would capture whether decision support of this kind would improve prescribing risk-adjusted sustainably
There is uncertainty whether current strategies for providing CVD risk scores  affect CVD events .
Providing CVD risk scores may slightly reduce CVD risk factor levels and may increase preventive medication prescribing in higher-risk people without evidence of harm .
BACKGROUND The current paradigm for cardiovascular disease ( CVD ) emphasises absolute risk assessment to guide treatment decisions in primary prevention .
Although the derivation and validation of multivariable risk assessment tools , or CVD risk scores , have attracted considerable attention , their effect on clinical outcomes is uncertain .
OBJECTIVES To assess the effects of evaluating and providing CVD risk scores in adults without prevalent CVD on cardiovascular outcomes , risk factor levels , preventive medication prescribing , and health behaviours .